The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

Pierre Deltenre, Alberto Zanetto, Dario Saltini, Christophe Moreno, Filippo Schepis – 3 June 2022 – In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt (TIPS) placement improves control of ascites and may reduce mortality. In this review, we summarize the current knowledge concerning the use of TIPS for the treatment of ascites in patients with cirrhosis, from pathophysiology of ascites formation to hemodynamic consequences, patient selection, and technical issues of TIPS insertion.

Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Akira Kajiwara, Hiroyuki Suzuki, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Kenta Murotani, Hironori Koga, Takuji Torimura – 2 June 2022 – In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and new embolization materials provided various options for transarterial chemoembolization (TACE), expanding the range of treatment strategies.

In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death

Kayvan Mohkam, David Nasralla, Hynek Mergental, Xavier Muller, Andrew Butler, Wayel Jassem, Charles Imber, Diethard Monbaliu, M. Thamara P. R. Perera, Richard W. Laing, Juan Carlos García‐Valdecasas, Andreas Paul, Federica Dondero, François Cauchy, Eric Savier, Olivier Scatton, Fabien Robin, Laurent Sulpice, Petru Bucur, Ephrem Salamé, Gabriella Pittau, Marc‐Antoine Allard, Pierre Pradat, Guillaume Rossignol, Jean‐Yves Mabrut, Rutger J. Ploeg, Peter J. Friend, Darius F.

Subscribe to